GR3022767T3 - Acylaminoindole derivatives as 5-ht1 agonists. - Google Patents

Acylaminoindole derivatives as 5-ht1 agonists.

Info

Publication number
GR3022767T3
GR3022767T3 GR970400451T GR970400451T GR3022767T3 GR 3022767 T3 GR3022767 T3 GR 3022767T3 GR 970400451 T GR970400451 T GR 970400451T GR 970400451 T GR970400451 T GR 970400451T GR 3022767 T3 GR3022767 T3 GR 3022767T3
Authority
GR
Greece
Prior art keywords
aryl
alkyl
alkylaryl
hydrogen
pct
Prior art date
Application number
GR970400451T
Other languages
English (en)
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR3022767T3 publication Critical patent/GR3022767T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Pyrrole Compounds (AREA)
GR970400451T 1992-04-10 1997-03-07 Acylaminoindole derivatives as 5-ht1 agonists. GR3022767T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10
PCT/US1993/001807 WO1993021180A1 (en) 1992-04-10 1993-03-04 Acylaminoindole derivatives as 5-ht1 agonists

Publications (1)

Publication Number Publication Date
GR3022767T3 true GR3022767T3 (en) 1997-06-30

Family

ID=25347493

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400451T GR3022767T3 (en) 1992-04-10 1997-03-07 Acylaminoindole derivatives as 5-ht1 agonists.

Country Status (31)

Country Link
US (1) US5498626A (el)
EP (1) EP0635015B1 (el)
JP (1) JP2544704B2 (el)
KR (1) KR0179074B1 (el)
CN (1) CN1038506C (el)
AT (1) ATE148465T1 (el)
AU (1) AU670270B2 (el)
BR (1) BR9306221A (el)
CA (1) CA2132706C (el)
CZ (1) CZ282653B6 (el)
DE (1) DE69307875T2 (el)
DK (1) DK0635015T3 (el)
EG (1) EG20466A (el)
ES (1) ES2097496T3 (el)
FI (2) FI111256B (el)
GR (1) GR3022767T3 (el)
HR (1) HRP930753B1 (el)
HU (1) HUT64060A (el)
IL (1) IL105309A0 (el)
MX (1) MX9301996A (el)
MY (1) MY115278A (el)
NO (1) NO309860B1 (el)
NZ (1) NZ251047A (el)
PL (1) PL172232B1 (el)
RU (1) RU2110516C1 (el)
SK (1) SK278182B6 (el)
TW (1) TW394769B (el)
UA (1) UA34452C2 (el)
WO (1) WO1993021180A1 (el)
YU (1) YU48916B (el)
ZA (1) ZA932536B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
SK280193B6 (sk) 1992-04-07 1999-09-10 Pfizer Inc. Indolové deriváty predstavujúce 5-ht1 agonisty, fa
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
DK0716649T3 (da) * 1993-08-31 1999-02-08 Pfizer 5-Arylindolderivater
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
FI971334A7 (fi) * 1994-08-03 1997-04-01 Asta Medica Ag Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
AU3170099A (en) * 1998-04-16 1999-11-08 Yamanouchi Pharmaceutical Co., Ltd. Remedies for obesity
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
JP2006516286A (ja) * 2003-01-22 2006-06-29 ジーティーエックス・インコーポレイテッド Ｓａｒｍによる女性のアンドロゲン減少に関連する病気の治療
CN101939306A (zh) * 2007-12-07 2011-01-05 美国辉瑞有限公司 反式-n-异丁基-3-氟-3-[3-氟-4-(吡咯烷-1-基-甲基)-苯基]环丁烷甲酰胺的甲苯磺酸盐
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
BR9206810A (pt) * 1991-11-25 1995-10-31 Pfizer Derivados de indol

Also Published As

Publication number Publication date
EP0635015B1 (en) 1997-01-29
MY115278A (en) 2003-05-31
UA34452C2 (uk) 2001-03-15
FI931613L (fi) 1993-10-11
US5498626A (en) 1996-03-12
ES2097496T3 (es) 1997-04-01
TW394769B (en) 2000-06-21
CZ282653B6 (cs) 1997-08-13
IL105309A0 (en) 1993-08-18
HU9301048D0 (en) 1993-06-28
DK0635015T3 (da) 1997-03-17
HRP930753B1 (en) 2000-10-31
RU94045902A (ru) 1996-08-27
WO1993021180A1 (en) 1993-10-28
DE69307875D1 (de) 1997-03-13
EP0635015A1 (en) 1995-01-25
FI931613A0 (fi) 1993-04-08
NO309860B1 (no) 2001-04-09
SK278182B6 (en) 1996-03-06
JPH07501831A (ja) 1995-02-23
ATE148465T1 (de) 1997-02-15
FI20010214L (fi) 2001-02-05
BR9306221A (pt) 1998-06-30
CA2132706C (en) 1998-08-04
CA2132706A1 (en) 1993-10-28
PL172232B1 (pl) 1997-08-29
NO943803D0 (no) 1994-10-07
YU25593A (sh) 1996-10-09
KR950700903A (ko) 1995-02-20
NO943803L (no) 1994-10-07
CZ247794A3 (en) 1995-07-12
ZA932536B (en) 1994-10-08
NZ251047A (en) 1996-09-25
DE69307875T2 (de) 1997-05-22
FI20010214A7 (fi) 2001-02-05
KR0179074B1 (ko) 1999-03-20
HUT64060A (en) 1993-11-29
CN1080288A (zh) 1994-01-05
EG20466A (en) 1999-05-31
FI111256B (fi) 2003-06-30
RU2110516C1 (ru) 1998-05-10
AU670270B2 (en) 1996-07-11
YU48916B (sh) 2002-11-15
HRP930753A2 (en) 1994-10-31
AU3782193A (en) 1993-11-18
MX9301996A (es) 1994-03-31
CN1038506C (zh) 1998-05-27
JP2544704B2 (ja) 1996-10-16
SK120794A3 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
HU9301048D0 (en) Acyl-amino-indole derivatives
MY108909A (en) Indole derivatives
TW229205B (el)
MY111683A (en) Indole derivatives.
DK0716649T3 (da) 5-Arylindolderivater
CA2117643A1 (en) Indole Derivatives